Community pharmacists experience of pregabalin abuse and misuse: A quantitative study from Jordan

References

• Albsoul-Younes, A., Wazaify, M., Yousef, A. M., & Tahaineh, L. (2010). Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan. Substance Use & Misuse, 45(9), 1319–1329. doi:10.3109/10826080802490683
   PubMed Web of Science ®Google Scholar
• Al-Husseini, A., Abufarha, R., Wazaify, M., & Van Hout, M. C. (2018). Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies. Saudi Pharmaceutical Journal, 26(3), 306–310. doi:10.1016/j.jsps.2018.01.012
   PubMed Web of Science ®Google Scholar
• Al-Husseini, A., Wazaify, M., & Van Hout, M. C. (2017). Pregabalin misuse and abuse in Jordan: A qualitative study of user experiences. International Journal of Mental Health and Addiction, 16(3), 642–654. doi:10.1007/s11469-017-9813-4
   PubMed Web of Science ®Google Scholar
• Al-Wazaify, M., & Albsoul-Younes, A. (2005). Pharmacy in Jordan. American Journal of Health-System Pharmacy, 62(23), 2548–2551. doi:10.2146/ajhp040368
   Web of Science ®Google Scholar
• Ball, K., & Wilde, M. (1989). OTC medicines misuse in West Cumbria. Pharmaceutical Journal, 242(6516), 40.
   Google Scholar
• Dole, E. J., & Tommasello, A. (2002). Recommendations for implementing effective substance abuse education in pharmacy practice. Substance Abuse, 23(S1), 263–271.
   PubMedGoogle Scholar
• Drug Enforcement Administration, Department of Justice. (2005). Schedules of controlled substances: Placement of pregabalin into schedule V. Final rule. Federal Register, 70(144), 43633.
   PubMedGoogle Scholar
• Fingleton, N. A., Watson, M. C., Duncan, E. M., & Matheson, C. (2016). Non-prescription medicine misuse, abuse and dependence: A cross-sectional survey of the UK general population. Journal of Public Health, 38(4), 722–730. doi:10.1093/pubmed/fdv204
   PubMed Web of Science ®Google Scholar
• Gahr, M., Freudenmann, R. W., Hiemke, C., Kölle, M. A., & Schönfeldt-Lecuona, C. (2013). Pregabalin abuse and dependence in Germany: Results from a database query. European Journal of Clinical Pharmacology, 69(6), 1335–1342. doi:10.1007/s00228-012-1464-6
   PubMed Web of Science ®Google Scholar
• Gahr, M., Freudenmann, R. W., Kölle, M. A., & Schönfeldt-Lecuona, C. (2014). Pregabalin and addiction: Lessons from published cases. Journal of Substance Use, 19(6), 448–449. doi:10.3109/14659891.2013.843725
   Web of Science ®Google Scholar
• Grosshans, M., Lemenager, T., Vollmert, C., Kaemmerer, N., Schreiner, R., Mutschler, J., & Hermann, D. (2013). Pregabalin abuse among opiate addicted patients. European Journal Of Clinical Pharmacology, 69(12), 2021-25.
   PubMed Web of Science ®Google Scholar
• Grover, P., Stewart, J., Hogg, M., Short, L., Seo, H. G., & Rew, A. (2011). Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Research in Social and Administrative Pharmacy, 7(3), 294–305. doi:10.1016/j.sapharm.2010.06.004
   PubMed Web of Science ®Google Scholar
• Hughes, G. F., McElnay, J. C., Hughes, C. M., & McKenna, P. (1999). Abuse/misuse of non-prescription drugs. Pharmacy World & Science, 21(6), 251–255. doi:10.1023/A:1008788726842
   PubMedGoogle Scholar
• Jaber, D., Bulatova, N., Suyagh, M., Yousef, A. M., & Wazaify, M. (2015). Knowledge, attitude and opinion of drug misuse and abuse by pharmacy students: A cross-sectional study in Jordan. Tropical Journal of Pharmaceutical Research, 14(8), 1501–1508. doi:10.4314/tjpr.v14i8.25
   Web of Science ®Google Scholar
• Jordan Food and drug Administration (JFDA). (2014), Formal statement about the restricted dispensing of pregabalin in Jordan. http://www.jfda.jo/EchoBusV3.0/SystemAssets/ce7e7f71-3158-4f56-92bd5ea766cbce16.jpg. Retrieved June 11, 2016.
   Google Scholar
• Jordan Food and Drug Administration (JFDA). Instructions for prescribing and medical records. 2017a. Retrieved from: http://www.jfda.jo/EchoBusV3.0/SystemAssets/PDF/AR/LawsAndRegulation/Drug/RegisterSection/2017.pdf
   Google Scholar
• Jordan Food and drug Administration (JFDA). (2017b), Formal statement about the restricted dispensing of pregabalin in Jordan. Can be obtained from URL: http://www.jfda.jo/EchoBusV3.0/SystemAssets/2f00f42e-427b-40ba-abf493adfb8c2ad6.jpg. Accessed May 10th 2017.
   Google Scholar
• Jordan Food and drug Administration (JFDA). (2017c), Pregabalin schedulingin Jordan. Can be obtained from URL: http://www.jfda.jo/EchoBusV3.0/SystemAssets/PDF/AR/LawsAndRegulation/Drug/DrugsAndPsychotropicSubstances.pdf
   Google Scholar
• Jordan Food and drug Administration (JFDA). 2018, Pharmacy and Drug law in Jordan for the year 2013. Can be obtained from: http://www.jfda.jo/Pages/viewpage.aspx?pageID=153http://www.jfda.jo/Pages/viewpage.aspx?pageID=153
   Google Scholar
• Jousilahti, P., Madkour, S. M., Lambrechts, T., & Sherwin, E. (1997). Diarrhoeal disease morbidity and home treatment practices in Egypt. Public Health, 111(1), 5–10.
   PubMed Web of Science ®Google Scholar
• Lessenger, J. E., & Feinberg, S. D. (2008). Abuse of prescription and over-the-counter medications. The Journal of the American Board of Family Medicine, 21(1), 45–54. doi:10.3122/jabfm.2008.01.070071
   PubMed Web of Science ®Google Scholar
• Loftus, H., & Wright, A. (2014). Potential misuse of pregabalin and gabapentin. BMJ (Clinical Research Ed.), 348, g1290. doi:10.1136/bmj.g1290
   PubMed Web of Science ®Google Scholar
• Manchikanti, L., Whitfield, E., & Pallone, F. (2005). Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician, 8(4), 335.
   PubMedGoogle Scholar
• Matowe, L., Ahmed Al-Kandery, A. S., & Bihzad, S. M. (2003). Pharmacy in Kuwait. American Journal of Health-System Pharmacy, 60(15), 1591–1592.
   PubMed Web of Science ®Google Scholar
• Millar, J, Sadasivan, S, Weatherup, N, & Lutton, S. (2013). Lyrica nights–recreational pregabalin abuse in an urban emergency department. Emergency Medicine Journal, 30(10), 874.
   Google Scholar
• National Institute on Drug Abuse (NIDA). (2014). Commonly abused drugs charts. Retrieved from. https://www.drugabuse.gov/drugs-abuse/commonly-abused-drugscharts. Accessed May 10th 2017.
   Google Scholar
• Papazisis, G., & Tzachanis, D. (2014). Pregabalin’s abuse potential: A mini review focusing on the pharmacological profile. International Journal of Clinical Pharmacology and Therapeutics, 52(8), 709–716. doi:10.5414/CP202118
   PubMed Web of Science ®Google Scholar
• Paxton, R., & Chapple, P. (1996). Misuse of over-the-counter medicines: A survey in one English county. Pharmaceutical Journal, 256(6881), 313–315.
   Google Scholar
• Schwan, S., Sundström, A., Stjernberg, E., Hallberg, E., & Hallberg, P. (2010). A signal for an abuse liability for pregabalin—Results from the Swedish spontaneous adverse drug reaction reporting system. European Journal of Clinical Pharmacology, 66(9), 947–953. doi:10.1007/s00228-010-0853-y
   PubMed Web of Science ®Google Scholar
• Sweileh, W. M., Arafat, R. T., Al-Khyat, L. S., Al-Masri, D. M., & Jaradat, N. A. (2004). A pilot study to investigate over-the-counter drug abuse and misuse in Palestine. Saudi Medical Journal, 25(12), 2029–2032.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C. (2014). “Doctor shopping and pharmacy hopping”: Practice innovations relating to codeine. Drugs and Alcohol Today, 14(4), 219–234. doi:10.1108/DAT-03-2014-0014
   Google Scholar
• Wazaify, M., Abood, E., Tahaineh, L., & Albsoul-Younes, A. (2016). Jordanian community pharmacists’ experience regarding prescription and nonprescription drug abuse and misuse in Jordan–An update. Journal of Substance Use, 22(5), 463–468.
   Web of Science ®Google Scholar
• Wazaify, M., Alali, M. B., Yousef, M. A., & Qammaz, S. (2017). Ophthalmic drops abuse in community pharmacy setting: A cross-sectional study from Jordan. Journal of Substance Use, 22(6), 656–660.
   Google Scholar
• Wazaify, M, Albsoul-Younes, A, Abu-Gharbieh, E, & Tahaineh, L. (2008). Societal perspectives on the role of the community pharmacist, over-the-counter (OTC) drugs and community-based pharmaceutical services in jordan. Pharmacy World And Science, 30(6), 884-91.
   PubMedGoogle Scholar
• Wazaify, M, Al-Bsoul-Younes, A, & Hakooz, N. (2010). Improving pharmacy education at the public faculties of pharmacy in Jordan: students’ experience and expectations. Pharmacy Education, 10(2), 107-13.
   Google Scholar
• Wazaify, M., Hughes, C. M., & McElnay, J. C. (2006). The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Education and Counseling, 64(1), 136–141. doi:10.1016/j.pec.2005.12.008
   PubMed Web of Science ®Google Scholar
• Wazaify, M., & Scott, J. (2017). Prescription/non-prescription medicine misuse and regulation–time for a modern, fit for purpose approach. Journal of Pharmacy Practice and Community Medicine, 3(4), 197–199. doi:10.5530/jppcm
   Google Scholar
• Wright, J., Bond, C., Robertson, H. D., & Matheson, C. (2015). Changes in over-the-counter drug misuse over 20 years: Perceptions from Scottish pharmacists. Journal of Public Health, 38(4), 793–799.
   Web of Science ®Google Scholar